首页 | 本学科首页   官方微博 | 高级检索  
     

维替泊芬治疗脉络膜骨瘤伴发的中心凹下脉络膜新生血管
引用本文:Nazimul Hussain Taraprasad Das. 维替泊芬治疗脉络膜骨瘤伴发的中心凹下脉络膜新生血管[J]. 国际眼科杂志, 2005, 5(5): 838-840
作者姓名:Nazimul Hussain Taraprasad Das
作者单位:印度海得拉巴L.V.普拉沙德眼科研究所
摘    要:目的:报道维替泊芬治疗脉络膜骨瘤伴发的中心凹下脉络膜新生血管(CNV)1例。方法:介入式个案报道结果:1例患者,32岁,确诊为右眼脉络膜骨瘤伴发性中心凹下脉络膜新生血管。治疗前视力20/80,N24。该患者右眼接受2次光动力治疗(PDT),治疗后12mo视力为20/200,CNV完全消退。结论:对于脉络膜骨瘤伴发的中心凹下脉络膜新生血管,PDT不失为一种治疗选择。

关 键 词:光动力治疗  维替泊芬  脉络膜新生血管  脉络膜骨瘤
收稿时间:2005-08-09
修稿时间:2005-09-20

Verteporfin therapy for subfoveal choroidal neovascularisation associated with choroidal osteoma
Nazimul Hussain,Taraprasad Das. Verteporfin therapy for subfoveal choroidal neovascularisation associated with choroidal osteoma[J]. International Eye Science, 2005, 5(5): 838-840
Authors:Nazimul Hussain  Taraprasad Das
Affiliation:Smt. Kanuri Santhamma Retina Vitreous Centre, L.V. Prasad Eye Institute, L.V. Prasad Marg, Banjara Hills, Hyderabad 500 034, Andhra Pradesh, India
Abstract:· AIM: To report a case of verteporfin therapy for subfoveal choroidal neovascularisation associated with choroidal osteoma.· METHODS: A 32-year-old patient was diagnosed as subfoveal choroidal neovascularisation (CNV) associated with choroidal osteoma in the right eye, with present visual acuity (VA) of 20/80; N24. He underwent 2 sessions of photodynamic therapy (PDT) in the right eye for 12mo.· RESULTS: At the end of 12mo, the patient's VA was 20/200 with complete regression of the CNV.· CONCLUSION: PDT could be a treatment option in subfoveal CNV associated with choroidal osteoma.
Keywords:photodynamic therapy   verteporfin  choroidal neovascularization   choroidal osteoma
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号